ABOUT THE PROVISION OF DRUGS IN THE ZHAMBYL REGION

The issue of urgent provision of medicines for the treatment of coronavirus infection to the population is under special control of the Government of RK.

As part of the fight against coronavirus infection, the Single distributor is taking measures to provide medical organizations of the country with medicines.

Since last year, medicines have been shipped to the country's medical organizations on a priority basis, continuously according to the schedule, according to the protocol for the diagnosis and treatment of coronavirus infection.

It is worth noting that the Single distributor purchases medicines in the volume formed by medical organizations and supplies them in accordance with the delivery schedule under contracts.

The shipment of medicines is carried out ahead of schedule, at the request of medical organizations.

In addition, for the uninterrupted supply of these drugs, medical organizations send additional requests for purchase and early shipment on a daily basis, which are processed promptly.

As for the availability of medicines for the treatment of coronavirus infection in the Zhambyl region, we inform you that today there are sufficient drugs in the hospitals of the region.

Indicated in the appeals of the population regarding the lack of medicines, they were shipped to medical organizations of the Zhambyl region by the Single distributor according to the concluded contracts:

- Dexamethasone solution for injection 4 mg / ml, 1 ml. in an amount of 601,830 units.

- Heparin solution for injection 5000 IU / ml, 5 ml. in the amount of 107,790 units.

- Methylprednisolone (Metipred) lyophilized powder for the preparation of a solution for injection of 250 mg in an amount of 7,920 units.

- Tocilizumab (Actemra) concentrate for the preparation of an infusion solution of 200 mg/10 ml, 10 ml in an amount of 145 units.

- Tocilizumab (Actemra) concentrate for the preparation of an infusion solution of 80 mg/4 ml, 4 ml in an amount of 54 units.

The Single distributor constantly monitors the availability of medicines, both in the warehouses of the Single distributor and in medical organizations.

In addition, the Public control after the appeals of the population, monitored the availability of medicines in medical organizations of the Zhambyl region. Monitoring of Public control showed that there are medicines in the hospitals of the region, and in sufficient quantities.

We remind you that for all questions of free medical provision, you can contact the contact center of "SK-Pharmacy" LLP by the short number 1439 (all calls are free of charge).

In order to prevent the spread of coronavirus infection, the Single distributor has taken a number of the following measures to create stocks of medicines in the warehouses of the Single distributor for timely and prompt shipment to medical organizations.

First: A monthly stock of drugs for the treatment of CVI has been provided in medical organizations, since the beginning of the year, drugs for 15.1 billion tenge has been shipped.

Second: A 2-month replenished stock of drugs was provided at the HUBs of the Single distributor for 38 positions of medicines for the treatment of Covid-19 in the amount of 6.4 billion tenge.

Third: 5 names of medicines were shipped in full within the framework of the ODP (antipyretic drugs: Paracetamol and Ibuprofen, anticoagulants: Rivaroxaban, Apixaban and Dabigatran).

Fourth: As part of the intervention in the retail network, a 2-month stock of 26 medicines in the amount of 1.8 billion tenge was formed and 10 million masks were purchased from 8 DP, according to the requests of the Akimats of the regions.

Fifth: Stocks of disposable protective suits (humanitarian aid) are provided, 200 thousand are stored at the HUBs of the Single distributor.

Sixth: A stock of disposable medical gloves has been formed at 4 hubs of the Single distributor, within the framework of a signed memorandum with "Chevron" company for the provision of humanitarian aid in the amount of 10 million pairs.

 For reference:

The purchase of medicines and medical products through the Single distributor is regulated by the Rules for organizing and conducting the purchase of medicines and medical products, pharmaceutical services, approved by Government Decree  №375.

The list of medicines included in the protocol of diagnosis and treatment of CVI is approved by the Ministry of Healthcare of RK.  The Joint Commission on the Quality of Medical Services (JCQ) of MHRK develops recommendations for improving clinical protocols and medical provision. On the basis of clinical protocols, the Formulary Commission of MHRK includes medicines in the orders and the list of the Single distributor for purchase. The protocol developers are leading infectious diseases specialists, pulmonologists and other clinical specialists of RK.

71 medical organizations are provided through the Single Distributor in Zhambyl region, including departments for the treatment of patients with coronavirus infection (CVI) are deployed in 20 of them. The shipment of medicines and MD to the address of these 20 medical organizations is carried out in a priority (unscheduled) order according to their requests.